Fundraising Fox

Ascend Advanced Therapies

Munich, DE · Founded 2022 · 97 employees on LinkedIn · 3 known investors

Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.

BiotechHealthtechMedical Devices

Investors · 3

Cathay HealthSan Franciscovia Eric De La Fortelle · inferred
Monograph Capital PartnersLondon
Digitalis VenturesreportedNew York · $100K – $10M

Competitors · 1

by search overlap
LeadIQ20 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.

Companies competing with Ascend Advanced Therapies for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Ascend Advanced Therapies do?
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.
Who are Ascend Advanced Therapies's investors?
Ascend Advanced Therapies's investors include Cathay Health, Monograph Capital Partners, Digitalis Ventures.
Where is Ascend Advanced Therapies headquartered?
Ascend Advanced Therapies is headquartered in Munich, DE.